OpenVSafe by OpenVAERS
Search V-safe

YD5-13787-53574

3 vaccinations 7 coded responses 36 check-ins 7 free-text entries 2 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
228 / VA
Registered
2021-01-22
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino
Registered dependents
B6H-21521-95601 Child or adolescent in my care · Female · 2021-11-20

Timeline

  1. 2021-01-21
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-22
    Registered in v-safe
  3. 2021-01-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness, Nausea
    Adult check-in
  4. 2021-01-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-01-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-28
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-02-04
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-02-11
    Dose 2 — Pfizer-BioNTech
  12. 2021-02-11
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  13. 2021-02-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to work
    Adult check-in
  14. 2021-02-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  15. 2021-02-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  16. 2021-02-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-02-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  18. 2021-02-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache
    Adult check-in
  19. 2021-02-18
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-02-25
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-03-04
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-03-11
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-03-18
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-03-25
    Survey response — day 42, dose 2
    MedDRA: Fatigue, Headache — Feeling: Good · Be unable to work
    Free text: Increased fatigue, more frequent headaches
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  25. 2021-05-13
    Survey response — 3 months, dose 2
    MedDRA: Menstruation irregular, Migraine — Feeling: Good · Be unable to work, Be unable to do your normal daily activities
    Free text: Menstrual cycle became very irregularfirst coming at 30 days and then at 52 days when it had been consistent at about 35 days for a long time. I have also been experiencing more frequent migraine-level headaches.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  26. 2021-08-12
    Survey response — 6 months, dose 2
    MedDRA: Abdominal pain, Fatigue, Intermenstrual bleeding, Menstruation irregular, Pain, Pelvic pain — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Menstrual cycle irregularity and breakthrough bleeding, fatigue, pelvic pain that radiates through the abdomen. Currently scheduled for pelvic ultrasound as a result.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  27. 2021-08-12
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  28. 2021-08-20
  29. 2021-10-22
    Dose 3 — Pfizer-BioNTech
  30. 2021-10-24
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  31. 2021-10-25
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  32. 2021-10-26
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Nausea
    Adult check-in
  33. 2021-10-27
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  34. 2021-10-28
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  35. 2021-10-29
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  36. 2021-11-07
    Survey response — day 14, dose 3
    MedDRA: Nasopharyngitis, Respiratory tract congestion, Sinusitis, Sneezing — Feeling: Fair
    Free text: Cold/sinus infection symptoms of congestion and sneezing
    MedDRA releases: 2024-11 · check-in free text available
  37. 2021-11-12
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  38. 2021-11-19
    Survey response — day 28, dose 3
    MedDRA: Arthralgia, Sinus congestion — Feeling: Good · Be unable to work or attend school
    Free text: Severe sinus congestion, joint pain
    MedDRA releases: 2024-11 · check-in free text available
  39. 2021-11-26
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  40. 2021-12-03
    Health check-in — day 42, dose 3
    Feeling: Fair
    Adult check-in
  41. 2022-01-21
    Survey response — 3 months, dose 3
    MedDRA: Cough, Oropharyngeal pain, Respiratory tract congestion, Respiratory tract infection, Sinusitis — Feeling: Good · Be unable to work or attend school
    Free text: Respiratory illness starting around 12/24. Began as sore throat, then moved to sinus infection-like congestion and a barking cough. The congestion and cough lasted for a little over 2 weeks, and I still experience occasional coughing.
    MedDRA releases: 2024-11 · check-in free text available
  42. 2022-04-22
    Survey response — 6 months, dose 3
    MedDRA: COVID-19, Cough, Fatigue, Heart rate increased, SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Tested positive for Covid in early February 2022. Since recovering, have experienced continued tiredness, and heart rate still has a higher resting rate than before. I experienced a cough and sudden rapid heartbeat for several weeks after Covid.
    MedDRA releases: 2024-11 · check-in free text available
  43. 2022-04-22
    Report sent to call center — 6 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  44. 2022-04-25

Vaccinations

DoseDateManufacturerCo-administered
12021-01-21Pfizer-BioNTech
22021-02-11Pfizer-BioNTech
32021-10-22Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-08-12 Unsuccessful
2022-04-22 Unsuccessful

Free text

Release 6 — day 42, dose 2

2021-03-25

Symptoms: Increased fatigue, more frequent headaches

Release 8 — 3 months, dose 2

2021-05-13

Symptoms: Menstrual cycle became very irregularfirst coming at 30 days and then at 52 days when it had been consistent at about 35 days for a long time. I have also been experiencing more frequent migraine-level headaches.

Release 9 — 6 months, dose 2

2021-08-12

Symptoms: Menstrual cycle irregularity and breakthrough bleeding, fatigue, pelvic pain that radiates through the abdomen. Currently scheduled for pelvic ultrasound as a result.

Release 10 — day 14, dose 3

2021-11-07

Symptoms: Cold/sinus infection symptoms of congestion and sneezing

Release 10 — day 28, dose 3

2021-11-19

Symptoms: Severe sinus congestion, joint pain

Release 11 — 3 months, dose 3

2022-01-21

Symptoms: Respiratory illness starting around 12/24. Began as sore throat, then moved to sinus infection-like congestion and a barking cough. The congestion and cough lasted for a little over 2 weeks, and I still experience occasional coughing.

Release 11 — 6 months, dose 3

2022-04-22

Symptoms: Tested positive for Covid in early February 2022. Since recovering, have experienced continued tiredness, and heart rate still has a higher resting rate than before. I experienced a cough and sudden rapid heartbeat for several weeks after Covid.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbdominal pain ✓ · ✓
SDArthralgia · · ✓
SDCough · · ✓
SDCOVID-19 · · ✓
SDFatigue ✓ ✓ ✓
SDHeadache ✓ ✓ ✓
SDHeart rate increased · · ✓
SDIntermenstrual bleeding ✓ · ✓
SDMenstruation irregular ✓ ✓ ✓
SDMigraine ✓ ✓ ✓
SDNasopharyngitis · · ✓
SDOropharyngeal pain · · ✓
SDPain ✓ · ✓
SDPelvic pain ✓ · ✓
SDRespiratory tract congestion · · ✓
SDRespiratory tract infection · · ✓
SDSARS-CoV-2 test positive · · ✓
SDSinus congestion · · ✓
SDSinusitis · · ✓
SDSneezing · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release